All In Biotech

Free tool

FAERS Monitor: Infuvite Adult

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021163 or its brand name (Infuvite Adult, Alpha-Tocopherol Acetate, Ascorbic Acid, Biotin, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Folic Acid, Niacinamide, Pyridoxine Hydrochloride, Riboflavin 5'-Phosphate Sodium, Thiamine Hydrochloride, Vitamin A Palmitate, Vitamin K). Reports on generic versions are filed under their own applications.

Reports

141

Serious

51

36% of reports

Hospitalization

11

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • flushing32
  • dyspnoea31
  • chest discomfort25
  • infusion related reaction18
  • nausea15
  • vomiting14
  • dizziness13
  • maternal exposure during pregnancy12
  • hypersensitivity10
  • anaphylactic reaction9
  • chest pain8
  • feeling abnormal8
  • oxygen saturation decreased8
  • anxiety7
  • cough7

Reports by year received

View as table
YearReports
20041
20052
20081
20092
20102
20112
20124
20132
20142
20151
20161
20173
20187
201913
202010
202114
202220
202318
202412
202510
202614

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,018 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
flushingSignal3247.034.61,400
infusion related reactionSignal1840.526.3657
chest discomfortSignal2536.425.5830
anaphylactic reactionSignal924.312.9179
oxygen saturation decreasedSignal821.210.8135
maternal exposure during pregnancySignal1220.111.7200
dyspnoeaSignal318.26.0193
hypersensitivitySignal108.04.455
chest painSignal86.43.332
feeling abnormalSignal85.02.522
vomitingSignal144.42.735
dizzinessSignal133.92.326
coughSignal73.71.812
anxietySignal73.71.811
nauseaSignal152.81.817

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.